Lv11
100 积分 2026-04-20 加入
Nonclinical Development of Oligonucleotide-Based Therapeutics: Insights from an IQ DruSafe ONT Working Group Survey
4小时前
待确认
Reduced Genotoxicity Testing Is Possible for Noncoding Oligonucleotide-Based Therapeutics Containing Well-Characterized Modifications: A European Regulatory Perspective
4个月前
已完结
Reduced Genotoxicity Testing Is Possible for Noncoding Oligonucleotide-Based Therapeutics Containing Well-Characterized Modifications: A European Regulatory Perspective
4个月前
已完结
Mechanistic Insights into Hybridization-Based Off-Target Activity of GalNAc-siRNA Conjugates
4个月前
已完结
小核酸药物临床研发和评价的思考
4个月前
已完结
Reduced Genotoxicity Testing Is Possible for Noncoding Oligonucleotide-Based Therapeutics Containing Well-Characterized Modifications: A European Regulatory Perspective
5个月前
已完结